View Older Stories View More Recent Stories

Aug 1, 2025 04:01PM Amgen (AMGN) Declares $2.38 Quarterly Dividend; 3.2% Yield
Jul 31, 2025 01:49PM Trump Posts Letters to Regeneron, Merck, AstraZeneca, GSK, Pfizer, Novo Nordisk, Amgen, Bristol-Myears, AbbVie, Novartis, Gilead, J&J on Truth Social
Jul 31, 2025 01:38PM White House: Trump took action on pharma Thursday, sent letters to CEOs
Jul 23, 2025 05:48AM Amgen (AMGN) PT Raised to $261 at BofA Securities
Jul 22, 2025 05:02AM Amgen (AMGN) PT Raised to $305 at Citi
Jul 21, 2025 05:45AM Amgen (AMGN) PT Raised to $326 at UBS
Jul 20, 2025 08:00PM U.S. large biotech stocks Q2 earnings preview
Jul 9, 2025 10:06AM Amgen (AMGN) PT Lowered to $335 at BMO Capital
Jul 1, 2025 10:05AM Piper Sandler on Amgen (AMGN): 'Another Clinical Win For The Oncology Franchise'
Jun 30, 2025 10:39AM William Blair Reiterates Outperform Rating on Amgen (AMGN)
Jun 30, 2025 09:01AM Amgen (AMGN) Announces Positive Topline Phase 3 Results For Bemarituzumab In Fibroblast Growth Factor Receptor 2B (Fgfr2B) Positive First-line Gastric Cancer
Jun 24, 2025 09:30AM TD Cowen Reiterates Buy Rating on Amgen (AMGN)
Jun 24, 2025 09:01AM BMO Capital Reiterates Outperform Rating on Amgen (AMGN)
Jun 24, 2025 08:54AM Truist Securities Reiterates Hold Rating on Amgen (AMGN)
Jun 24, 2025 08:21AM Piper Sandler Reiterates Overweight Rating on Amgen (AMGN)
Jun 24, 2025 06:45AM Cantor Fitzgerald Reiterates Neutral Rating on Amgen (AMGN)
Jun 23, 2025 02:31PM Amgen (AMGN) reports full results from Part 1 of the Phase 2 study of MariTide
May 22, 2025 01:19PM Jefferies Downgrades Vigil Neuroscience Inc (VIGL) to Hold
May 16, 2025 09:48AM Amgen (AMGN) PT Trimmed to $328 at Piper Sandler
May 15, 2025 02:04PM Regeneron (REGN) Prevails over Amgen (AMGN) in Antitrust PCSK9 Lawsuit Protecting Biotech Innovation and Patient Access to Life-Saving Treatments
May 12, 2025 11:17AM Popular stocks volume: AMGN GILD JNJ LLY MRK PFE SNY AZN GSK NVS BMY NVO CVS CI UNH CAH MCK COR W RH
May 8, 2025 05:51AM Erste Group Downgrades Amgen (AMGN) to Hold
May 7, 2025 05:29AM Amgen (AMGN) option IV flat
May 2, 2025 10:16AM Cantor Fitzgerald Reiterates Neutral Rating on Amgen (AMGN)
May 2, 2025 05:26AM Stocks expected to have increasing option volume: SYK AMGN FIVN CART TWLO BMRN PCTY JNPR WEN CI CYTK TWLO
May 1, 2025 04:03PM Amgen (AMGN) Tops Q1 EPS by 61c; offers guidance
Apr 30, 2025 10:40AM Amgen (AMGN) call put ratio 3.3 calls to 1 put into quarter results
Apr 25, 2025 01:02PM Amgen (AMGN) confirms $900M Ohio manufacturing expansion
Apr 25, 2025 11:50AM Amgen (AMGN) Announces $900 Million Expansion Of Ohio Drugmaking Plant - Bloomberg
Apr 24, 2025 08:23AM Piper Sandler Reiterates Overweight Rating on Amgen (AMGN)
Apr 22, 2025 08:03AM Cantor Fitzgerald Reiterates Neutral Rating on Amgen (AMGN)
Apr 22, 2025 07:19AM Cantor Fitzgerald Assumes Amgen (AMGN) at Neutral
Apr 14, 2025 01:07PM Piper Sandler Reiterates Overweight Rating on Amgen (AMGN)
Apr 14, 2025 10:17AM Amgen (AMGN) PT Raised to $319 at UBS
Apr 12, 2025 04:00AM Biotech sector Q1 earnings preview from RBC Capital Markets
Apr 11, 2025 09:02AM Amgen (AMGN): Imdelltra Demonstrated Superior Overall Survival In Small Cell Lung Cancer
Apr 9, 2025 09:19AM Pharma stocks slide after Trump signals tariffs on sector
Apr 4, 2025 08:10AM Piper Sandler Reiterates Overweight Rating on Amgen (AMGN)
Apr 3, 2025 04:00PM Citi Reiterates Neutral Rating on Amgen (AMGN)
Apr 3, 2025 03:36PM Amgen (AMGN): Uplizna Is Now The First And Only Fda-approved Treatment For Igg4-related Disease
Apr 3, 2025 02:51PM FDA Approves Amgen's (AMGN) Uplizna for Treatment of Immunoglobulin G4-Related Disease in Adult Patients - Website
Apr 1, 2025 09:33AM Bernstein Assesses U.S. Biopharma Stocks Amid Tariff Risks
Mar 26, 2025 06:00PM Weighing in on obesity: Catalyst-rich 2025 ahead in a growing competitive landscape
Mar 26, 2025 09:45AM Truist Weighs In on Obesity: 'Catalyst-Rich 2025 Ahead in a Growing Competitive Landscape'
Mar 25, 2025 08:16AM Piper Sandler on Amgen (AMGN): 'Repatha Remains a Standout'
Mar 18, 2025 06:52AM Cantor Fitzgerald says more options, newer targets will expand obesity market
Mar 15, 2025 04:00PM Bernstein provides 2025 M&A outlook for U.S. Biotech and Pharma
Mar 13, 2025 09:01AM Amgen (AMGN) Reports New UPLIZNA Data
Mar 10, 2025 11:33AM TD Cowen Reiterates Buy Rating on Amgen (AMGN) as 'ROCA PH3 Horizon Shows Improved Safety'
Mar 5, 2025 09:26AM Amgen (AMGN) Starts Late-stage Studies Of Monthly Obesity Drug - Bloomberg, Citing Comments at Conf.
View More Recent Stories View Older Stories